ISIN DK0030488101 - Tryg Forsikring A/S Has Determined The Purchase Price
Reference is made to the announcement published 20 October 2026. All capitalised terms used and not otherwise defined herein shall have the meanings assigned thereto in the announcement unless the context otherwise requires. Tryg Forsikring A/S (the "Issuer") has now determined the purchase price for the contemplated purchase of some or all of the outstanding SEK 1,300,000,000 Floating Rate Tier 2 Capital Notes, ISIN DK0030488101 (the "Existing Notes"). The purchase price will be 100.042 per cent. of their Outstanding Principal Amount (as defined in the terms and conditions of the Existing Notes) at the date of settlement of the purchase together with any accrued and unpaid interest to (but excluding) the date of settlement of the purchase. The Issuer's purchase of the Existing Notes is conditional upon certain Purchase Conditions, among other things, the successful completion of the issuance and settlement of the Notes.
Additional information:
For further information, visit tryg.com or contact:
Head of Financial Reporting, Gianandrea Roberti at +45 20 18 82 67 or ...
Head of Investor Relations, Robin H. Løfgren at +45 41 86 25 88 or ...
This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer, invitation or solicitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities or otherwise in any jurisdiction in which such offer, invitation or solicitation is unlawful.
This announcement does not constitute a prospectus, prospectus equivalent document or an exempted document.
Attachment
-
Tryg Forsikring AS Purchase Price Announcement

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment